States / New York / S 36

S 36 Enacted

Relates to the labeling of mifepristone, misoprostol, and their generic alternatives

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted

Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.

Chamber
Senate
Introduced
Jan 8, 2025
Last action
Feb 3, 2025 — APPROVAL MEMO.1
Session
2025-2026
Momentum
91 · Very high